Correlation Between Protalix Biotherapeutics and OCUP Old
Can any of the company-specific risk be diversified away by investing in both Protalix Biotherapeutics and OCUP Old at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protalix Biotherapeutics and OCUP Old into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protalix Biotherapeutics and OCUP Old, you can compare the effects of market volatilities on Protalix Biotherapeutics and OCUP Old and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protalix Biotherapeutics with a short position of OCUP Old. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protalix Biotherapeutics and OCUP Old.
Diversification Opportunities for Protalix Biotherapeutics and OCUP Old
-0.58 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Protalix and OCUP is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Protalix Biotherapeutics and OCUP Old in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OCUP Old and Protalix Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protalix Biotherapeutics are associated (or correlated) with OCUP Old. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OCUP Old has no effect on the direction of Protalix Biotherapeutics i.e., Protalix Biotherapeutics and OCUP Old go up and down completely randomly.
Pair Corralation between Protalix Biotherapeutics and OCUP Old
If you would invest 176.00 in Protalix Biotherapeutics on October 9, 2024 and sell it today you would earn a total of 48.00 from holding Protalix Biotherapeutics or generate 27.27% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 5.0% |
Values | Daily Returns |
Protalix Biotherapeutics vs. OCUP Old
Performance |
Timeline |
Protalix Biotherapeutics |
OCUP Old |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Protalix Biotherapeutics and OCUP Old Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Protalix Biotherapeutics and OCUP Old
The main advantage of trading using opposite Protalix Biotherapeutics and OCUP Old positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protalix Biotherapeutics position performs unexpectedly, OCUP Old can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OCUP Old will offset losses from the drop in OCUP Old's long position.Protalix Biotherapeutics vs. Corvus Pharmaceuticals | Protalix Biotherapeutics vs. Aldeyra | Protalix Biotherapeutics vs. Checkpoint Therapeutics | Protalix Biotherapeutics vs. Cidara Therapeutics |
OCUP Old vs. Reviva Pharmaceuticals Holdings | OCUP Old vs. Protalix Biotherapeutics | OCUP Old vs. Eyepoint Pharmaceuticals | OCUP Old vs. Sellas Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |